Taxifolin: complete India guide

India has one of the highest rates of micronutrient deficiency in the world — and the supplement market is growing fast to meet it. But with hundreds of products on Amazon.in and little regulation, knowing what to actually buy is harder than it should be. This guide covers Taxifolin from first principles: what it is, what the evidence says, and how to use it safely in an Indian context.

What is Taxifolin?

Taxifolin (dihydroquercetin, DHQ) is the reduced form of quercetin, lacking the C2–C3 double bond. This structural

Taxifolin is relevant for anyone dealing with Capillary fragility. It primarily acts on the Blood vessels.

How does Taxifolin work?

Taxifolin scavenges hydroxyl and superoxide radicals, inhibits lipid peroxidation, and protects capillary integrity

Who should take Taxifolin?

Adults seeking capillary and vascular antioxidant support, or those who want flavonoid benefits with potentially better

The typical dose is 100–200 mg/day. Once or twice daily with meals

Safety and who should avoid it

No major contraindications. May mildly inhibit CYP3A4 and CYP2C9 at high doses. Those on medications metabolized by

Always consult your doctor before starting any new supplement, particularly if you are on prescription medication or have an existing health condition.

How to combine Taxifolin

Taxifolin works well alongside calcium alpha ketoglutarate. The Ayurvedic tradition has long used bhumi amalaki, kutki for similar purposes — these can complement rather than replace each other.

Buying guide for India

When shopping on Amazon.in, prioritise products that clearly state:

• The standardised active compound percentage
• Third-party testing (NSF, USP, or Informed Sport)
• The form of Taxifolin (extract vs whole herb vs isolate)
• Vegetarian capsule certification if that matters to you

Generic “natural” or “herbal” labels without standardisation information are a red flag. The price difference between a well-made and a poorly-made Taxifolin supplement is often small — the difference in efficacy is not.

Bottom line

Taxifolin has Key citations: Abenavoli 2010 (hepatoprotection systematic review), Cacciapuoti 2013 (NAFLD RCT). ri for Capillary fragility. Used consistently at the right dose, it is a reasonable addition to a wellness protocol for those dealing with these concerns.